Health Economics›Classical Hodgkin lymphoma›Untreated advanced stage

Untreated advanced stage

Classical Hodgkin lymphoma · 25 regimens

Cost estimates only — modelled on a typical patient (BSA 1.7 m², 70 kg, CrCl 90 mL/min) using the cheapest available formulary presentation. Excludes vial wastage, facility fees, supportive care, and infusion consumables. Not for billing, formulary decisions, or clinical use.

Filters

Y-axis

Cost vs Efficacy

No data points — cost or PFS missing for current selection.

Regimen	Biomarker	Cost/cycle ↓	Cycle	PFS ↕	OS ↕	Est. cycles	Course cost ↕	Evidence
A-AVD Variant #01	—	R 116 574	28d	—	—	—	—	2
BrECADD Variant #01	—	R 89 316	21d	—	—	—	—	1
RABVD Variant #01	—	R 73 691	28d	—	—	—	—	—
ChlVPP/PABIOE Variant #01 Partial	—	R 5 255	28d	—	—	—	—	—
eBEACOPP-BEACOPP Variant #01 Partial	—	R 4 580	21d	—	—	—	—	—
LOPP/EVAP Variant #01 Partial	—	R 4 275	28d	—	—	—	—	—
ABVD, DD-DI Variant #01	—	R 3 586	21d	—	—	—	—	—
MOPP/ABVD Variant #01 Partial	—	R 3 342	28d	—	—	—	—	—
eBEACOPP Variant #01 Partial	—	R 2 945	21d	—	—	—	—	2
N-AVD Variant #01 Partial	—	R 2 916	28d	—	—	—	—	1
AVD Variant #01	—	R 2 916	28d	—	—	—	—	—
ABVD Variant #01	—	R 2 916	28d	—	—	—	—	4
Stanford V Variant #05 Partial	—	R 2 608	28d	—	—	—	—	1
VEBEP Variant #01	—	R 2 416	21d	—	—	—	—	—
BEACOPP-14 Variant #01 Partial	—	R 1 672	14d	—	—	—	—	—
BEACOPP Variant #01 Partial	—	R 1 672	21d	—	—	—	—	—
LOPP Variant #01 Partial	—	R 1 613	28d	—	—	—	—	—
C-MOPP/ABV Variant #01 Partial	—	R 1 017	28d	—	—	—	—	—
MOPP-ABV Variant #01 Partial	—	R 862	28d	—	—	—	—	—
SCAB Variant #01 Partial	—	R 431	30d	—	—	—	—	—
CVPP Variant #01 Partial	—	R 430	28d	—	—	—	—	—
MVPP Variant #01 Partial	—	R 430	28d	—	—	—	—	—
BCVPP Variant #01 Partial	—	R 429	28d	—	—	—	—	—
COPP (CCNU) Variant #01 Partial	—	R 426	28d	—	—	—	—	—
MOPP Variant #01 Partial	—	R 426	28d	—	—	—	—	—

25 of 25 regimens shown